Literature DB >> 10099239

Enhanced secretion of human granulocyte colony-stimulating factor directed by a novel hybrid fusion peptide from recombinant Saccharomyces cerevisiae at high cell concentration.

C S Bae1, D S Yang, K R Chang, B L Seong, J Lee.   

Abstract

The synthesis and secretion of recombinant human granulocyte colony-stimulating factor (rhG-CSF) are investigated in fed-batch cultures at high cell concentration of recombinant Saccharomyces cerevisiae, and some important characteristics of the secreted rhG-CSF are demonstrated. Transcription of the recombinant gene is regulated by a GAL1-10 upstream activating sequence (UASG), and the rhG-CSF is expressed in a hybrid fusion protein consisting of signal sequence of Kluyveromyces lactis killer toxin and N-terminal 24 amino acids of human interleukin 1beta. The intracellular KEX2 cleavage leads to excretion of mature rhG-CSF into extracellular culture broth, and the cleavage process seems to be highly efficient. In spite of relatively low copy number the plasmid propagation is stably maintained even at nonselective culture conditions. The rhG-CSF synthesis does not depend on galactose level, whereas the production of extracellular rhG-CSF was significantly enhanced by increasing the inducer concentration above a certain level and also by supplementing the nonionic surfactant to the culture medium, which is notably due to the enhanced secretion efficiency. Various immunoblotting analyses demonstrate that none of the rhG-CSF is accumulated in the cell wall fraction and that a significant amount of intracellular rhG-CSF antibody-specific immunoreactive proteins is located in the ER. A core N-glycosylation at fused IL-1beta fragment is likely to play a critical role in directing the high-level secretion of rhG-CSF, and the O-glycosylation of secreted rhG-CSF seems nearly negligible. Also the extracellular rhG-CSF is observed to exist as various multimers, and the nature of molecular interaction is evidently not the covalent disulfide bridges. The CD spectra of purified rhG-CSF and Escherichia coli-derived standard show that the conformations of both are similar and are almost identical to that reported for natural hG-CSF. Copyright 1998 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10099239     DOI: 10.1002/(sici)1097-0290(19980305)57:5<600::aid-bit12>3.0.co;2-f

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

1.  Human granulocyte colony-stimulating factor (hG-CSF) expression in plastids of Lactuca sativa.

Authors:  Mehdi Sharifi Tabar; Ali Akbar Habashi; Hamid Rajabi Memari
Journal:  Iran Biomed J       Date:  2013

2.  Role of cultivation media in the development of yeast strains for large scale industrial use.

Authors:  Bärbel Hahn-Hägerdal; Kaisa Karhumaa; Christer U Larsson; Marie Gorwa-Grauslund; Johann Görgens; Willem H van Zyl
Journal:  Microb Cell Fact       Date:  2005-11-10       Impact factor: 5.328

3.  Transient co-expression with three O-glycosylation enzymes allows production of GalNAc-O-glycosylated Granulocyte-Colony Stimulating Factor in N. benthamiana.

Authors:  Israel A Ramírez-Alanis; Justin B Renaud; Silverio García-Lara; Rima Menassa; Guy A Cardineau
Journal:  Plant Methods       Date:  2018-11-06       Impact factor: 4.993

Review 4.  Exploiting virus-like particles as innovative vaccines against emerging viral infections.

Authors:  Hotcherl Jeong; Baik Lin Seong
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

5.  Human granulocyte colony stimulating factor (hG-CSF): cloning, overexpression, purification and characterization.

Authors:  Ana Ls Vanz; Gaby Renard; Mario S Palma; Jocelei M Chies; Sérgio L Dalmora; Luiz A Basso; Diógenes S Santos
Journal:  Microb Cell Fact       Date:  2008-04-04       Impact factor: 5.328

6.  Human G-CSF synthesis using stress-responsive bacterial proteins.

Authors:  Jong-Am Song; Kyung-Yeon Han; Jin-Seung Park; Hyuk-Seong Seo; Keum-Young Ahn; Jeewon Lee
Journal:  FEMS Microbiol Lett       Date:  2009-05-05       Impact factor: 2.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.